Skip to content
Screener

Bio-Rad Laboratories BIO Asia Pacific — Net Sales

Other geography segments

Europe
$206.8M+3.5%
Americas
$45.1M+13.3%

Similar metrics at other companies

Amcor logo
AMCRAsia Pacific — Net Sales
$503M+30.0%
Brady Corporation logo
BRCAsia Pacific — Net Sales
$38.39M+13.8%
3M logo
MMMAsia Pacific — Net Sales
$1.87B+4.9%
Sanmina Corp logo
SANMAsia Pacific — Net Sales
$725.21M+18.4%
Quaker Houghton logo
KWRAsia/Pacific — Net Sales
$124.67M+24.8%
Avery Dennison logo
AVYAsia Pacific — Net Sales
$408.9M+14.1%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.3B+30.0%
Enterprise value$9.78B+19.3%
P/E55.1×+32.7×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000012208-26-000035
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
United States$229.8$241.7
EMEA206.8199.8
APAC110.4104.1
Other (primarily Canada and Latin America)45.139.8
Total net sales$592.1$585.4

Item 1. Financial Statements (Unaudited)

FAQ

What is Bio-Rad Laboratories's asia pacific — net sales?
Bio-Rad Laboratories (BIO) reported asia pacific — net sales of $110.4M in Q1 2026.
How has Bio-Rad Laboratories's asia pacific — net sales changed year-over-year?
Bio-Rad Laboratories's asia pacific — net sales increased by 6.1% year-over-year, from $104.1M to $110.4M.
What is the long-term trend for Bio-Rad Laboratories's asia pacific — net sales?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's asia pacific — net sales has grown at a -7.1% compound annual growth rate (CAGR), from $688.4M to $513.3M.
What does asia pacific — net sales mean?
This metric represents the total revenue generated from the sale of clinical diagnostics and life science products within the Asia Pacific geographic region. It reflects the company's market penetration, demand for research and diagnostic solutions, and overall commercial success in these specific international markets. Tracking this figure helps investors assess the company's geographic diversification and growth momentum in emerging and established Asian economies.

Ask your AI about Bio-Rad Laboratories's asia pacific — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude